Quantum Biopharma (QNTM) Free Cash Flow (2019 - 2026)
Quantum Biopharma recorded quarterly Free Cash Flow of -$1.7 million in Q1 2026, down 446.06% quarter-over-quarter from -$305598.0 in Q4 2025, and up 60.84% year-over-year from -$1.0 million in Q1 2025.
Quantum Biopharma's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 60.84% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$5.6 million (up 38.4% YoY), while the FY2025 annual figure was -$8.2 million, down 19.79% from the prior year.
- Free Cash Flow came in at -$1.7 million for Q1 2026 at Quantum Biopharma, down from -$305598.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $9.4 million in Q2 2022 to a low of -$50.6 million in Q4 2022.
- A 4-year average of -$3.5 million and a median of -$1.7 million in 2026 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow soared 65.96% in 2022 and plunged 221.38% in 2025, its largest moves.
- Quantum Biopharma's Free Cash Flow stood at -$50.6 million in 2022, then soared by 98.35% to -$835762.0 in 2024, then soared by 63.43% to -$305598.0 in 2025, then slumped by 446.06% to -$1.7 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$1.7 million, -$305598.0, and -$1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -354.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.67 Mn |
| Mar 31, 2026 | -1.67 Mn |
| Dec 31, 2025 | -305,598.00 |
| Dec 31, 2025 | -305,598.00 |
| Sep 30, 2025 | -1.72 Mn |
| Sep 30, 2025 | -1.72 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Mar 31, 2025 | -4.26 Mn |
| Mar 31, 2025 | -4.26 Mn |
| Dec 31, 2024 | -835,762.00 |
| Dec 31, 2024 | -835,762.00 |
| Sep 30, 2024 | -3.46 Mn |
| Sep 30, 2024 | -3.46 Mn |
| Jun 30, 2024 | -606,482.00 |
| Jun 30, 2024 | -606,482.00 |
| Mar 31, 2024 | -1.97 Mn |
| Mar 31, 2024 | -1.97 Mn |
| Dec 31, 2022 | -50.57 Mn |
| Dec 31, 2022 | -50.57 Mn |
| Sep 30, 2022 | 7.61 Mn |
| Sep 30, 2022 | 7.61 Mn |
| Jun 30, 2022 | 9.40 Mn |
| Jun 30, 2022 | 9.40 Mn |
| Mar 31, 2022 | 5.11 Mn |
| Mar 31, 2022 | 5.11 Mn |
| Dec 31, 2021 | -37.40 Mn |
| Dec 31, 2021 | -37.40 Mn |
| Sep 30, 2021 | 4.59 Mn |
| Sep 30, 2021 | 4.59 Mn |
| Jun 30, 2021 | 6.58 Mn |
| Jun 30, 2021 | 6.58 Mn |
| Mar 31, 2021 | 5.48 Mn |
| Mar 31, 2021 | 5.48 Mn |
| Sep 30, 2020 | -7.41 Mn |
| Sep 30, 2020 | -7.41 Mn |
| Jun 30, 2020 | -2.68 Mn |
| Jun 30, 2020 | -2.68 Mn |
| Mar 31, 2020 | -4.10 Mn |
| Mar 31, 2020 | -4.10 Mn |
| Mar 31, 2019 | 3.01 Mn |
| Mar 31, 2019 | 3.01 Mn |